Dr. Megan Kalambo is a breast imaging radiologist at The University of Texas MD Anderson Cancer Center (MDACC) and Clinical Medical...

Holds a Master degree in biochemistry from the Univerté du Québec à Montréal and is responsible for the clinical research operations. He...

SurgMark GmbH today announced that the U.S. Food & Drug Administration (FDA) has issued a 510(k) premarket notification for its...

Biomaterial in breast cancer diagnostics: Hamburg-based start-up SurgMark presents SchurSign® Tissue Marker at MEDICA/COPAMED 2023...

The Future of Early Detection Unveiled In a significant stride towards redefining breast cancer diagnostics, Hamburg-based start-up...

Press Release Medical technology start-up SurgMark aims to enter the US market FDA Approval Sought for Biocompatible SchurSign® Tissue...

In December 2021, production of the marker could be started under GMP and cleanroom conditions. The first markers will be produced for...

Dr Christine König was elected by the members to the BGB Board of Life Science Nord (LSN) e.V. as treasurer. LSN has over 270 members...